pk 11195 has been researched along with Lysosomal Enzyme Disorders, Nervous System in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Visigalli, I | 1 |
| Moresco, RM | 1 |
| Belloli, S | 1 |
| Politi, LS | 1 |
| Gritti, A | 1 |
| Ungaro, D | 1 |
| Matarrese, M | 1 |
| Turolla, E | 1 |
| Falini, A | 1 |
| Scotti, G | 1 |
| Naldini, L | 1 |
| Fazio, F | 1 |
| Biffi, A | 1 |
1 other study available for pk 11195 and Lysosomal Enzyme Disorders, Nervous System
| Article | Year |
|---|---|
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195.
Topics: Animals; Brain; Carbon Radioisotopes; Central Nervous System Diseases; Demyelinating Diseases; Disea | 2009 |